.png){kind=icon}
.png){kind=icon}
Return
Oral macrocyclic PCSK9 inhibitor secures FDA approval
.png){kind=icon}
PRE
AI
A
DOI：10.1038/d41573-026-00123-4.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Journal
IF:
101.8
Papers:
5.1K
Citations:
5.3W
Organization
No organization information available
Cited Papers